BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29175372)

  • 1. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
    Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
    Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
    Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
    Front Immunol; 2020; 11():293. PubMed ID: 32194553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired burrowing is the most prominent behavioral deficit of aging htau mice.
    Geiszler PC; Barron MR; Pardon MC
    Neuroscience; 2016 Aug; 329():98-111. PubMed ID: 27167086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.
    Ali YO; Ruan K; Zhai RG
    Hum Mol Genet; 2012 Jan; 21(2):237-50. PubMed ID: 21965302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
    Komuro Y; Xu G; Bhaskar K; Lamb BT
    Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.
    Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G
    Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
    Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
    Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
    Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
    Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nmnat1 protects neuronal function without altering phospho-tau pathology in a mouse model of tauopathy.
    Musiek ES; Xiong DD; Patel T; Sasaki Y; Wang Y; Bauer AQ; Singh R; Finn SL; Culver JP; Milbrandt J; Holtzman DM
    Ann Clin Transl Neurol; 2016 Jun; 3(6):434-42. PubMed ID: 27547771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy.
    Ljungberg MC; Ali YO; Zhu J; Wu CS; Oka K; Zhai RG; Lu HC
    Hum Mol Genet; 2012 Jan; 21(2):251-67. PubMed ID: 22027994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Nmnat1 leads to a retina-specific decrease of NAD+ accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration.
    Greenwald SH; Brown EE; Scandura MJ; Hennessey E; Farmer R; Du J; Wang Y; Pierce EA
    Hum Mol Genet; 2021 May; 30(8):644-657. PubMed ID: 33709122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
    Sasaki Y; Vohra BP; Lund FE; Milbrandt J
    J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.
    Polydoro M; Acker CM; Duff K; Castillo PE; Davies P
    J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide mononucleotide adenylyltransferase uses its NAD
    Ma X; Zhu Y; Lu J; Xie J; Li C; Shin WS; Qiang J; Liu J; Dou S; Xiao Y; Wang C; Jia C; Long H; Yang J; Fang Y; Jiang L; Zhang Y; Zhang S; Zhai RG; Liu C; Li D
    Elife; 2020 Apr; 9():. PubMed ID: 32250733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
    Chang JK; Leso A; Subaiea GM; Lahouel A; Masoud A; Mushtaq F; Deeb R; Eid A; Dash M; Bihaqi SW; Zawia NH
    Curr Alzheimer Res; 2018; 15(7):655-663. PubMed ID: 29357795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    Dengler-Crish CM; Smith MA; Wilson GN
    J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
    Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
    Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.